The potential benefits of using Bi(III) as an alternative to zinc in antibiotic binding include its potential effectiveness in combating antibiotic resistance and its ability to target specific bacterial strains. However, limitations may include potential toxicity concerns and the need for further research to fully understand its efficacy and safety compared to zinc.